Copyright
        ©The Author(s) 2025.
    
    
        World J Gastroenterol. Sep 21, 2025; 31(35): 108139
Published online Sep 21, 2025. doi: 10.3748/wjg.v31.i35.108139
Published online Sep 21, 2025. doi: 10.3748/wjg.v31.i35.108139
            Table 1 Binding affinities and interaction of ambroxol with different protein targets
        
    | Lowest binding energy (kcal/mol) | Polar bonds | Hydrophobic interactions | |
| Cytoglobin | -5.1 | Val47, Val51, Arg48, Pro69 | |
| TXNRD1 | -6.6 | Glu477, Thr480 | Val474, Cys475, Ile347, Pro344, Thr481, Val478, Phe406 | 
| HMGB1 | -4.9 | Ser12, Ala13, Asn46 | Lys39, Gly42, Ala38, Phe14 | 
- Citation: Alruhaimi RS, Hassanein EHM, Alnasser SM, Ahmeda AF, Althagafy HS, Abd El-Ghafar OAM, Mahmoud AM. Ambroxol mitigates cyclophosphamide-induced liver injury by suppressing TLR-4/NF-κB signaling and oxidative stress and upregulating cytoglobin, TXNRD1 and HMGB1. World J Gastroenterol 2025; 31(35): 108139
 - URL: https://www.wjgnet.com/1007-9327/full/v31/i35/108139.htm
 - DOI: https://dx.doi.org/10.3748/wjg.v31.i35.108139
 
